Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Sleep and PTSD Exposure Therapy
NCT02849548Phase 4Completed
- Sponsor
- Howard University
- Start
- Jan 2017
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suvorexant in post-traumatic stress disorder (PTSD), sponsored by Howard University. Started Jan 2017; status: completed.
02
Drugs
suvorexant
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02849548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02849548.